Mike Byrnes

Michael Byrnes is currently a Member of the Board of Directors at CERo Therapeutics, Inc. Prior to this role, Michael served as the Chief Financial Officer at eFFECTOR Therapeutics, Inc. and Principia Biopharma. Michael has a strong background in finance, holding various leadership positions in companies like Alkahest, Inc., Ocera Therapeutics, Maxygen, NeurogesX, Inc., Lipid Sciences, ADAC Laboratories, and Bay View Capital. Michael earned their BSC in Finance from Santa Clara University and later pursued an MBA in Finance from California State University - East Bay.